COMPARATIVE IMMUNE MICROENVIRONMENT PROFILING IN HBV-, HCV-, AND DUAL-INFECTED HEPATOCELLULAR CARCINOMA: TOWARD ETIOLOGY-SPECIFIC IMMUNOTHERAPEUTIC TARGETS. (2025). Frontier in Medical and Health Research, 3(4), 843-845. https://fmhr.net/index.php/fmhr/article/view/478